$30 Million for Kidney Cancer Research
Bryan Lewis2019-05-21T10:04:21-04:00The U.S. House Appropriations Committee released its report accompanying the FY20 Defense Appropriations Act. It contains an increase to $30 million
IKCC Global Kidney Cancer Summit 2019
Bryan Lewis2019-04-06T20:05:48-04:00Our President, Bryan Lewis represented KidneyCan at the 9th global summit for Kidney Cancer in Lisbon, Portugal. IKCC (International Kidney Cancer
First In Human Trial for Kidney Cancer: Watching and Waiting
Brenda Knapp2019-04-06T20:44:57-04:00The treatment part of this Phase 1 clinical trial for kidney cancer is over, now we're in the watching and waiting phase.
Clinical trials are vital to Medical Research
Brenda Knapp2019-03-30T17:54:28-04:00My husband is participating in a first in human or Phase 1 clinical trial. This trial is for kidney cancer and
NCI Leader in Kidney Cancer
Bryan Lewis2019-03-30T14:25:14-04:00Bryan Lewis, Ralph & Brenda Knapp, founders of KidneyCan had the pleasure of sitting down with
Letter submitted to Congressional Leadership
Brenda Knapp2019-03-29T16:35:04-04:00KidneyCan submitted a letter to the Congressional leadership of the House Appropriations Committee in early March. The letter was hand delivered
First In Human: So Far, So Good
Brenda Knapp2019-03-29T18:40:19-04:00My husband Ralph is in his 4th day of a First In Human clinical trial at NIH. He is patient #3.
First in Human: Infusion Day
Brenda Knapp2019-03-26T18:42:02-04:00Day zero: Super T-cell infusion day! Ralph received his new T-cells on 3/25 at 11:54 am. What an exciting day for
First in Human: Waiting for the Super T-Cells
Brenda Knapp2019-04-02T10:52:00-04:00My husband is participating in a clinical trial at NIH. It's a Phase 1, First in Human trial for kidney cancer.
First In Human Clinical Trial
Brenda Knapp2019-03-28T18:08:03-04:00My husband has a chance for a cure. He is patient #3 in a first in human clinical trial for kidney